Toxin-antitoxin systems in clinical pathogens

Toxins

Volumn 8, Issue 7, 2016, Pages

  Fernández García, Laura ^a   Blasco, Lucia ^a   Lopez, Maria ^a,b   Bou, German ^a,b   García Contreras, Rodolfo ^c   Wood, Thomas ^d,e   Tomas, María ^a,b  

^a HOSPITAL JUAN CANALEJO   (Spain)

^b Spanish Network for Research in Infectious Diseases ^*  (Spain)

^c UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^d The Pennsylvania State University   (United States)

^e PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

Chromosome; Clinical; Pathogens; Persistance; Plasmids; Resistance; Toxin antitoxin; Virulence

Indexed keywords

ANTITOXIN; BACTERIAL ENZYME; EXTENDED SPECTRUM BETA LACTAMASE; TOXIN; ANTIINFECTIVE AGENT; BACTERIAL TOXIN;

ACINETOBACTER BAUMANNII; BACTERIAL PHENOMENA AND FUNCTIONS; BACTERIAL STRAIN; BIOFILM; BIOINFORMATICS; BURKHOLDERIA; CHROMOSOME; ENTEROBACTER; ENTEROCOCCUS FAECIUM; ESCHERICHIA COLI; KLEBSIELLA PNEUMONIAE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PLASMID; PSEUDOMONAS AERUGINOSA; QUORUM SENSING; REVIEW; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS; STREPTOCOCCUS PNEUMONIAE; STRESS; TOXIN ANTITOXIN SYSTEM; ANIMAL; ANTIBIOTIC RESISTANCE; BACTERIAL INFECTION; BACTERIUM; DRUG EFFECTS; HOST PATHOGEN INTERACTION; HUMAN; METABOLISM; MICROBIOLOGY; PATHOGENICITY; VIRULENCE;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTITOXINS; BACTERIA; BACTERIAL INFECTIONS; BACTERIAL TOXINS; DRUG RESISTANCE, BACTERIAL; HOST-PATHOGEN INTERACTIONS; HUMANS; VIRULENCE;

EID: 84979277026     PISSN: None     EISSN: 20726651     Source Type: Journal    
DOI: 10.3390/toxins8070227     Document Type: Review

References (154)

1. Makarova, K.S.; Wolf, Y.I.; Koonin, E.V. Comprehensive comparative-genomic analysis of type 2 toxin-antitoxin systems and related mobile stress response systems in prokaryotes. Biol. Direct. 2009, 4. [CrossRef] [PubMed]
2. Yamaguchi, Y.; Park, J.H.; Inouye, M. Toxin-antitoxin systems in bacteria and archaea. Annu. Rev. Genet. 2011, 45, 61-79. [CrossRef] [PubMed]
3. Mutschler, H.; Gebhardt, M.; Shoeman, R.L.; Meinhart, A. A novel mechanism of programmed cell death in bacteria by toxin-antitoxin systems corrupts peptidoglycan synthesis. PLoS Biol. 2011, 9. [CrossRef] [PubMed]
4. Unoson, C.;Wagner, E.G. A small SOS-induced toxin is targeted against the inner membrane in Escherichia coli. Mol. Microbiol. 2008, 70, 258-270. [CrossRef] [PubMed]
5. Leplae, R.; Geeraerts, D.; Hallez, R.; Guglielmini, J.; Drèze, P.; Van Melderen, L. Diversity of bacterial type II toxin-antitoxin systems: a comprehensive search and functional analysis of novel families. Nucleic Acids Res. 2011, 39, 5513-5525. [CrossRef] [PubMed]
6. Gerdes, K.; Rasmussen, P.B.; Molin, S. Unique type of plasmid maintenance function: postsegregational killing of plasmid-free cells. Proc. Natl. Acad. Sci. USA 1986, 83, 3116-3120. [CrossRef] [PubMed]
7. Van Melderen, L.; Saavedra De Bast, M. Bacterial toxin-antitoxin systems: more than selfish entities? PLoS Genet. 2009, 5. [CrossRef] [PubMed]
8. Mochizuki, A.; Yahara, K.; Kobayashi, I.; Iwasa, Y. Genetic addiction: selfish gene’s strategy for symbiosis in the genome. Genetics. 2006, 172, 1309-1323. [CrossRef] [PubMed]
9. Van Melderen, L. Toxin-antitoxin systems: why so many, what for? Curr. Opin. Microbiol. 2010, 13, 781-785. [CrossRef] [PubMed]
10. Lehnherr, H.; Maguin, E.; Jafri, S.; Yarmolinsky, M.B. Plasmid addiction genes of bacteriophage P1: doc, which causes cell death on curing of prophage, and phd, which prevents host death when prophage is retained. J. Mol. Biol. 1993, 233, 414-428. [CrossRef] [PubMed]
11. Ramage, H.R.; Connolly, L.E.; Cox, J.S. Comprehensive functional analysis of Mycobacterium tuberculosis toxin-antitoxin systems: implications for pathogenesis, stress responses, and evolution. PLoS Genet. 2009, 5. [CrossRef] [PubMed]
12. Yamaguchi, Y.; Inouye, M. mRNA interferases, sequence-specific endoribonucleases from the toxin-antitoxin systems. Prog. Mol. Biol. Transl. Sci. 2009, 85, 467-500.
13. Schuster, C.F.; Bertram, R. Toxin-antitoxin systems are ubiquitous and versatile modulators of prokaryotic cell fate. FEMS Microbiol. Lett. 2013, 340, 73-85. [CrossRef] [PubMed]
14. Wang, X.; Lord, D.M.; Cheng, H.Y.; Osbourne, D.O.; Hong, S.H.; Sanchez-Torres, V.; Quiroga, C.; Zheng, K.; Herrmann, T.; Peti,W.; et al. A new type V toxin-antitoxin system where mRNA for toxin GhoT is cleaved by antitoxin GhoS. Nat. Chem. Biol. 2012, 8, 855-861. [CrossRef] [PubMed]
15. Fair, R.J.; Tor, Y. Antibiotics and bacterial resistance in the 21st century. Perspect. Medicin. Chem. 2014, 6, 25-64. [PubMed]
16. Pendleton, J.N.; Gorman, S.P.; Gilmore, B.F. Clinical relevance of the ESKAPE pathogens. Expert Rev. Anti Infect. Ther. 2013, 11, 297-308. [CrossRef] [PubMed]
17. Kim, Y.;Wang, X.; Ma, Q.; Zhang, X.S.;Wood, T.K. Toxin-antitoxin systems in Escherichia coli influence biofilm formation through YjgK (TabA) and fimbriae. J. Bacteriol. 2009, 191, 1258-1267. [CrossRef] [PubMed]
18. Gerdes, K.; Maisonneuve, E. Bacterial persistence and toxin-antitoxin loci. Annu. Rev. Microbiol. 2012, 66, 103-123. [CrossRef] [PubMed]
19. Kolodkin-Gal, I.; Verdiger, R.; Shlosberg-Fedida, A.; Engelberg-Kulka, H. A differential effect of E. coli toxin-antitoxin systems on cell death in liquid media and biofilm formation. PLoS ONE 2009, 4. [CrossRef] [PubMed]
20. Brantl, S. Bacterial type I toxin-antitoxin systems. RNA Biol. 2012, 9, 1488-1490. [CrossRef] [PubMed]
21. Patel, S.;Weaver, K.E. Addiction toxin Fst has unique effects on chromosome segregation and cell division in Enterococcus faecalis and Bacillus subtilis. J. Bacteriol. 2006, 188, 5374-5384. [CrossRef] [PubMed]
22. Halvorsen, E.M.;Williams, J.J.; Bhimani, A.J.; Billings, E.A.; Hergenrother, P.J. Txe, an endoribonuclease of the enterococcal Axe-Txe toxin-antitoxin system, cleaves mRNA and inhibits protein synthesis. Microbiology 2011, 157, 387-397. [CrossRef] [PubMed]
23. Sletvold, H.; Johnsen, P.J.; Hamre, I.; Simonsen, G.S.; Sundsfjord, A.; Nielsen, K.M. Complete sequence of Enterococcus faecium pVEF3 and the detection of an omega-epsilon-zeta toxin-antitoxin module and an ABC transporter. Plasmid 2008, 60, 75-85. [CrossRef] [PubMed]
24. Rosvoll, T.C.; Pedersen, T.; Sletvold, H.; Johnsen, P.J.; Sollid, J.E.; Simonsen, G.S.; Jensen, L.B.; Nielsen, K.M.; Sundsfjord, A. PCR-based plasmid typing in Enterococcus faecium strains reveals widely distributed pRE25-, pRUM-, pIP501- and pHTbeta-related replicons associated with glycopeptide resistance and stabilizing toxin-antitoxin systems. FEMS Immunol. Med. Microbiol. 2010, 58, 254-268. [CrossRef] [PubMed]
25. Soheili, S.; Ghafourian, S.; Sekawi, Z.; Neela, V.K.; Sadeghifard, N.; Taherikalani, M.; Khosravi, A.; Ramli, R.; Hamat, R.A. The mazEF toxin-antitoxin system as an attractive target in clinical isolates of Enterococcus faecium and Enterococcus faecalis. Drug Des. Devel. Ther. 2015, 9, 2553-2561. [PubMed]
26. Bukowski, M.; Lyzen, R.; Helbin, W.M.; Bonar, E.; Szalewska-Palasz, A.; Wegrzyn, G.; Dubin, G.; Dubin, A.; Wladyka, B. A regulatory role for Staphylococcus aureus toxin-antitoxin system PemIKSa. Nat. Commun. 2013, 4. [CrossRef] [PubMed]
27. Pinel-Marie, M.L.; Brielle, R.; Felden, B. Dual toxic-peptide-coding Staphylococcus aureus RNA under antisense regulation targets host cells and bacterial rivals unequally. Cell. Rep. 2014, 7, 424-435. [CrossRef] [PubMed]
28. Schuster, C.F.; Bertram, R. Toxin-Antitoxin Systems of Staphylococcus aureus. Toxins (Basel) 2016, 8. [CrossRef] [PubMed]
29. Sayed, N.; Nonin-Lecomte, S.; Réty, S.; Felden, B. Functional and structural insights of a Staphylococcus aureus apoptotic-like membrane peptide from a toxin-antitoxin module. J. Biol. Chem. 2012, 287, 43454-43463. [CrossRef] [PubMed]
30. Donegan, N.P.; Cheung, A.L. Regulation of the mazEF toxin-antitoxin module in Staphylococcus aureus and its impact on sigB expression. J. Bacteriol. 2009, 191, 2795-2805. [CrossRef] [PubMed]
31. Schuster, C.F.; Mechler, L.; Nolle, N.; Krismer, B.; Zelder, M.E.; Götz, F.; Bertram, R. The MazEF Toxin-Antitoxin System Alters the _-Lactam Susceptibility of Staphylococcus aureus. PLoS ONE 2015, 10. [CrossRef] [PubMed]
32. Fu, Z.; Tamber, S.; Memmi, G.; Donegan, N.P.; Cheung, A.L. Overexpression of MazFsa in Staphylococcus aureus induces bacteriostasis by selectively targeting mRNAs for cleavage. J. Bacteriol. 2009, 191, 2051-2059. [CrossRef] [PubMed]
33. Yoshizumi, S.; Zhang, Y.; Yamaguchi, Y.; Chen, L.; Kreiswirth, B.N.; Inouye, M. Staphylococcus aureus YoeB homologues inhibit translation initiation. J. Bacteriol. 2009, 191, 5868-5872. [CrossRef] [PubMed]
34. Larson, A.S.; Hergenrother, P.J. Light activation of Staphylococcus aureus toxin YoeBSa1 reveals guanosine-specific endoribonuclease activity. Biochemistry 2014, 53, 188-201. [CrossRef] [PubMed]
35. Wei, Y.Q.; Bi, D.X.; Wei, D.Q.; Ou, H.Y. Prediction of Type II Toxin-Antitoxin Loci in Klebsiella pneumoniae Genome Sequences. Interdiscip. Sci. 2016, 8, 143-149. [CrossRef] [PubMed]
36. Tashiro, Y.; Kawata, K.; Taniuchi, A.; Kakinuma, K.; May, T.; Okabe, S. RelE-mediated dormancy is enhanced at high cell density in Escherichia coli. J. Bacteriol. 2012, 194, 1169-1176. [CrossRef] [PubMed]
37. Ghafourian, S.; Good, L.; Sekawi, Z.; Hamat, R.A.; Soheili, S.; Sadeghifard, N.; Neela, V. The mazEF toxin-antitoxin system as a novel antibacterial target in Acinetobacter baumannii. Mem. Inst. Oswaldo Cruz. 2014, 109, 502-505. [CrossRef] [PubMed]
38. Mosqueda, N.; Gato, E.; Roca, I.; López, M.; de Alegría, C.R.; Fernández Cuenca, F.; Martínez-Martínez, L.; Pachón, J.; Cisneros, J.M.; Rodríguez-Baño, J. Characterization of plasmids carrying the blaOXA-24/40 carbapenemase gene and the genes encoding the AbkA/AbkB proteins of a toxin/antitoxin system. J. Antimicrob. Chemother. 2014, 69, 2629-2633. [CrossRef] [PubMed]
39. Chan, K.G.; Atkinson, S.; Mathee, K.; Sam, C.K.; Chhabra, S.R.; Cámara, M.; Koh, C.L.; Williams, P. Characterization of N-acylhomoserine lactone-degrading bacteria associated with the Zingiber officinale (ginger) rhizosphere: co-existence of quorum quenching and quorum sensing in Acinetobacter and Burkholderia. BMC Microbiol. 2011, 11. [CrossRef] [PubMed]
40. Bonnin, R.A.; Poirel, L.; Nordmann, P.; Eikmeyer, F.G.; Wibberg, D.; Pühler, A.; Schlüter, A. Complete sequence of broad-host-range plasmid pNOR-2000 harbouring the metallo-_-lactamase gene blaVIM-2 from Pseudomonas aeruginosa. J. Antimicrob. Chemother. 2013, 68, 1060-1065. [CrossRef] [PubMed]
41. Tamman, H.; Ainelo, A.; Ainsaar, K.; Hõrak, R. A Moderate Toxin, GraT, Modulates Growth Rate and Stress Tolerance of Pseudomonas putida. J. Bacteriol. 2014, 196, 157-169. [CrossRef] [PubMed]
42. Williams, J.J.; Halvorsen, E.M.; Dwyer, E.M.; DiFazio, R.M.; Hergenrother, P.J. Toxin-antitoxin (TA) systems are prevalent and transcribed in clinical isolates of Pseudomonas aeruginosa and methicillin-resistant Staphylococcus aureus. FEMS Microbiol. Lett. 2011, 322, 41-50. [CrossRef] [PubMed]
43. Williams, J.J.; Halvorsen, E.M.; Dwyer, E.M.; DiFazio, R.M.; Hergenrother, P.J. Toxin-antitoxin (TA) systems are prevalent and transcribed in clinical isolates of Pseudomonas aeruginosa and methicillin-resistant Staphylococcus aureus. FEMS Microbiol. Lett. 2011, 322, 41-50. [CrossRef] [PubMed]
44. Wood, T.L.; Wood, T.K. The HigB/HigA toxin/antitoxin system of Pseudomonas aeruginosa influences the virulence factors pyochelin, pyocyanin, and biofilm formation. Microbiol. Open 2016, 5. [CrossRef] [PubMed]
45. Ainelo, A.; Tamman, H.; Leppik, M.; Remme, J.; Hõrak, R. The toxin GraT inhibits ribosome biogenesis. Mol. Microbiol. 2016, 100, 719-731. [CrossRef] [PubMed]
46. Kim, Y.; Wood, T.K. Toxins Hha and CspD and small RNA regulator Hfq are involved in persister cell formation through MqsR in Escherichia coli. Biochem. Biophys. Res. Commun. 2010, 391, 209-213. [CrossRef] [PubMed]
47. Dörr, T.; Vulić, M.; Lewis, K. Ciprofloxacin causes persister formation by inducing the TisB toxin in Escherichia coli. PLoS Biol. 2010, 8, 8. [CrossRef] [PubMed]
48. Ren, D.; Walker, A.N.; Daines, D.A. Toxin-antitoxin loci vapBC-1 and vapXD contribute to survival and virulence in nontypeable Haemophilus influenzae. BMC Microbial. 2012, 12. [CrossRef] [PubMed]
49. Garcia-Contreras, R.; Zhang, X.S.; Kim, Y.; Wood, T.K. Protein translation and cell death: the role of rare tRNAs in biofilm formation and in activating dormant phage killer genes. PLoS ONE 2008, 3. [CrossRef] [PubMed]
50. Norton, J.P.; Mulvey, M.A. Toxin-Antitoxin Systems Are Important for Niche-Specific Colonization and Stress Resistance of Uropathogenic Escherichia coli. PLoS Pathog. 2012, 8. [CrossRef] [PubMed]
51. Wang, J.; Stephan, R.; Zurfluh, K.; Hächler, H.; Fanning, S. Characterization of the genetic environment of bla ESBL genes, integrons and toxin-antitoxin systems identified on large transferrable plasmids in multi-drug resistant Escherichia coli. Front. Microbiol. 2014, 5. [CrossRef]
52. Schaufler, K.; Wieler, L.H.; Semmler, T.; Ewers, C.; Guenther, S. ESBL-plasmids carrying toxin-antitoxin systems can be "cured" of wild-type Escherichia coli using a heat technique. Gut Pathog. 2013, 5. [CrossRef] [PubMed]
53. Vogel, J.; Argaman, L.;Wagner, E.G.; Altuvia, S. The small RNA IstR inhibits synthesis of an SOS-induced toxic peptide. Curr. Biol. 2004, 14, 2271-2276. [CrossRef] [PubMed]
54. Kawano, M.; Aravind, L.; Storz, G. An antisense RNA controls synthesis of an SOS-induced toxin evolved from an antitoxin. Mol. Microbiol. 2007, 64, 738-754. [CrossRef] [PubMed]
55. Engelberg-Kulka, H.; Hazan, R.; Amitai, S. mazEF: A chromosomal toxin-antitoxin module that triggers programmed cell death in bacteria. J. Cell. Sci. 2005, 118, 4327-4332. [CrossRef] [PubMed]
56. Hazan, R.; Engelberg-Kulka, H. Escherichia coli mazEF-mediated cell death as a defense mechanism that inhibits the spread of phage P1. Mol. Genet. Genomics. 2004, 272, 227-234. [CrossRef] [PubMed]
57. Christensen, S.K.; Pedersen, K.; Hansen, F.G.; Gerdes, K. Toxin-antitoxin loci as stress-response-elements: ChpAK/MazF and ChpBK cleave translated RNAs and are counteracted by tmRNA. J. Mol. Biol. 2003, 332, 809-819. [CrossRef]
58. Zhang, Y.; Zhang, J.; Hara, H.; Kato, I.; Inouye, M. Insights into the mRNA cleavage mechanism by MazF, an mRNA interferase. J. Biol. Chem. 2005, 280, 3143-3150. [CrossRef] [PubMed]
59. Pedersen, K.; Zavialov, A.V.; Pavlov, M.Y.; Elf, J.; Gerdes, K.; Ehrenberg, M. The bacterial toxin RelE displays codon-specific cleavage of mRNAs in the ribosomal A site. Cell 2003, 112, 131-140. [CrossRef]
60. Zhang, Y.; Inouye, M. The inhibitory mechanism of protein synthesis by YoeB, an Escherichia coli toxin. J. Biol. Chem. 2009, 284, 6627-6638. [CrossRef] [PubMed]
61. Wang, X.; Kim, Y.; Hong, S.H.; Ma, Q.; Brown, B.L.; Pu, M.; Tarone, A.M.; Benedik, M.J.; Peti,W.; Page, R.; et al. Antitoxin MqsA helps mediate the bacterial general stress response. Nat. Chem. Biol. 2011, 7, 359-366. [CrossRef] [PubMed]
62. Cheng, H.Y.; Soo, V.W.; Islam, S.; McAnulty, M.J.; Benedik, M.J.; Wood, T.K. Toxin GhoT of the GhoT/GhoS toxin/antitoxin system damages the cell membrane to reduce adenosine triphosphate and to reduce growth under stress. Environ. Microbiol. 2014, 16, 1741-1754. [CrossRef] [PubMed]
63. Van Acker, H.; Sass, A.; Dhondt, I.; Nelis, H.J.; Coenye, T. Involvement of toxin-antitoxin modules in Burkholderia cenocepacia biofilm persistence. Pathog. Dis. 2014, 71, 326-335. [CrossRef] [PubMed]
64. Butt, A.; Higman, V.A.; Williams, C.; mp, M.P.; Hemsley, C.M.; Harmer, N.; Titball, R.W. The HicA toxin from Burkholderia pseudomallei has a role in persister cell formation. Biochem. J. 2014, 459, 333-344. [CrossRef] [PubMed]
65. Kirkpatrick, B.; Reeves, D.S.; MacGowan, A.P. A review of the clinical presentation, laboratory features, antimicrobial therapy and outcome of 77 episodes of pneumococcal meningitis occurring in children and adults. J. Infect. 1994, 29, 171-182. [CrossRef]
66. Chan, W.T.; Nieto, C.; Harikrishna, J.A.; Khoo, S.K.; Othman, R.Y.; Espinosa, M.; Yeo, C.C. Genetic regulation of the yefM-yoeB toxin-antitoxin locus of Streptococcus pneumoniae. J. Bacteriol. 2011, 193, 4612-4625. [CrossRef] [PubMed]
67. Mutschler, H.; Reinstein, J.; Meinhart, A. Assembly dynamics and stability of the pneumococcal epsilon zeta antitoxin toxin (PezAT) system from Streptococcus pneumoniae. J. Biol. Chem. 2010, 285, 21797-21806. [CrossRef] [PubMed]
68. Chan, W.T.; Moreno-Cordoba, I.; Yeo, C.C.; Espinosa, M. Toxin-antitoxin genes of the Gram-positive pathogen Streptococcus pneumoniae: so few and yet so many. Microbiol. Mol. Biol. Rev. 2012, 76, 773-791. [CrossRef] [PubMed]
69. Sala, A.; Bordes, P.; Genevaux, P. Multiple toxin-antitoxin systems in Mycobacterium tuberculosis. Toxins (Basel) 2014, 6, 1002-1020. [CrossRef] [PubMed]
70. Gupta, A. Killing activity and rescue function of genome-wide toxin-antitoxin loci of Mycobacterium tuberculosis. FEMS Microbiol. Lett. 2009, 290, 45-53. [CrossRef] [PubMed]
71. Smollett, K.L.; Fivian-Hughes, A.S.; Smith, J.E.; Chang, A.; Rao, T.; Davis, E.O. Experimental determination of translational start sites resolves uncertainties in genomic open reading frame predictions - application to Mycobacterium tuberculosis. Microbiol. 2009, 155, 186-197. [CrossRef] [PubMed]
72. Stewart, G.R.;Wernisch, L.; Stabler, R.; ngan, J.A.; Hinds, J.; Laing, K.G.; Young, D.B.; Butcher, P.D. Dissection of the heat-shock response in Mycobacterium tuberculosis using mutants and microarrays. Microbiol. 2002, 148, 3129-3138. [CrossRef] [PubMed]
73. Tailleux, L.;Waddell, S.J.; Pelizzola, M.; Mortellaro, A.;Withers, M.; Tanne, A.; Castagnoli, P.R.; Gicquel, B.; Stoker, N.G.; Butcher, P.D.; et al. Probing host pathogen cross-talk by transcriptional profiling of both Mycobacterium tuberculosis and infected human dendritic cells and macrophages. PLoS ONE 2008, 3. [CrossRef] [PubMed]
74. Huang, F.; He, Z.G. Characterization of an interplay between a Mycobacterium tuberculosis MazF homolog, Rv1495 and its sole DNA topoisomerase I. Nucleic Acids Res. 2010, 38, 8219-8230. [CrossRef] [PubMed]
75. Ghafourian, S.; Raftari, M.; Sadeghifard, N.; Sekawi, Z. Toxin-antitoxin Systems: Classification, Biological Function and Application in Biotechnology. Curr. Issues Mol. Biol. 2014, 16, 9-14. [PubMed]
76. Dy, R.L.; Richter, C.; Salmond, G.P.; Fineran, P.C. Remarkable Mechanisms in Microbes to Resist Phage Infections. Annu. Rev. Virol. 2014, 1, 307-331. [CrossRef] [PubMed]
77. Karimi, S.; Ghafourian, S.; Taheri Kalani, M.; Azizi Jalilian, F.; Hemati, S.; Sadeghifard, N. Association between toxin-antitoxin systems and biofilm formation. Jundishapur J. Microbiol. 2015, 8. [CrossRef] [PubMed]
78. Miller,W.R.; Munita, J.M.; Arias, C.A. Mechanisms of antibiotic resistance in enterococci. Expert Rev. Anti Infect. Ther. 2014, 12, 1221-1236. [CrossRef] [PubMed]
79. Weaver, K.E.; Reddy, S.G.; Brinkman, C.L.; Patel, S.; Bayles, K.W.; Endres, J.L. Identification and characterization of a family of toxin-antitoxin systems related to the Enterococcus faecalis plasmid pAD1 par addiction module. Microbiology 2009, 155, 2930-2940. [CrossRef] [PubMed]
80. Grady, R.; Hayes, F. Axe-Txe, a broad-spectrum proteic toxin-antitoxin system specified by a multidrug-resistant, clinical isolate of Enterococcus faecium. Mol. Microbiol. 2003, 47, 1419-1432. [CrossRef] [PubMed]
81. Goeders, N.; Van Melderen, L. Toxin-antitoxin systems as multilevel interaction systems. Toxins (Basel) 2014, 6, 304-324. [CrossRef] [PubMed]
82. Fozo, E.M.; Makarova, K.S.; Shabalina, S.A.; Yutin, N.; Koonin, E.V.; Storz, G. Abundance of type I toxin-antitoxin systems in bacteria: Searches for new candidates and discovery of novel families. Nucleic Acids Res. 2010, 38, 3743-3759. [CrossRef] [PubMed]
83. Zhu, L.; Inoue, K.; Yoshizumi, S.; Kobayashi, H.; Zhang, Y.; Ouyang, M.; Kato, F.; Sugai, M.; Inouye, M. Staphylococcus aureus MazF specifically cleaves a pentad sequence, UACAU, which is unusually abundant in the mRNA for pathogenic adhesive factor SraP. J. Bacteriol. 2009, 191, 3248-3255. [CrossRef] [PubMed]
84. Locke, J.B.; Rahawi, S.; Lamarre, J.; Mankin, A.S.; Shaw, K.J. Genetic environment and stability of cfr in methicillin-resistant Staphylococcus aureus CM05. Antimicrob. Agents Chemother. 2012, 56, 332-340. [CrossRef] [PubMed]
85. Dmowski, M.; Sitkiewicz, I.; Ceglowski, P. Characterization of a novel partition system encoded by the delta and omega genes from the streptococcal plasmid pSM19035. J. Bacteriol. 2006, 188, 4362-4372. [CrossRef] [PubMed]
86. Khoo, S.K.; Loll, B.; Chan, W.T.; Shoeman, R.L.; Ngoo, L.; Yeo, C.C.; Meinhart, A. Molecular and structural characterization of the PezAT chromosomal toxin-antitoxin system of the human pathogen Streptococcus pneumoniae. J. Biol. Chem. 2007, 282, 19606-19618. [CrossRef] [PubMed]
87. Peleg, A.Y.; Seifert, H.; Paterson, D.L. Acinetobacter baumannii: Emergence of a successful pathogen. Clin. Microbiol. Rev. 2008, 21, 538-582. [CrossRef] [PubMed]
88. Chastre, J.; Trouillet, J.L. Problem pathogens (Pseudomonas aeruginosa and Acinetobacter). Semin. Respir. Infect. 2000, 15, 287-298. [CrossRef] [PubMed]
89. Smith, M.G.; Gianoulis, T.A.; Pukatzki, S.; Mekalanos, J.J.; Ornston, L.N.; Gerstein, M.; Snyder, M. New insights into Acinetobacter baumannii pathogenesis revealed by high-density pyrosequencing and transposon mutagenesis. Genes Dev. 2007, 21, 601-614. [CrossRef] [PubMed]
90. Jurenaite, M.; Markuckas, A.; Suziedeliene, E. Identification and characterization of type II toxin-antitoxin systems in the opportunistic pathogen Acinetobacter baumannii. J. Bacteriol. 2013, 195, 3165-3172. [CrossRef] [PubMed]
91. Lean, S.S.; Yeo, C.C.; Suhaili, Z.; Thong, K.L. Comparative Genomics of Two ST 195 Carbapenem-Resistant Acinetobacter baumannii with Different Susceptibility to Polymyxin Revealed Underlying Resistance Mechanism. Front. Microbiol. 2015, 6. [CrossRef]
92. Mace, C.; Seyer, D.; Chemani, C.; Cosette, P.; Di-Martino, P.; Guery, B.; Filloux, A.; Fontaine, M.; Molle, V.; Junter, G.A.; et al. Identification of biofilm-associated cluster (bac) in Pseudomonas aeruginosa involved in biofilm formation and virulence. PLoS ONE 2008, 3. [CrossRef] [PubMed]
93. Moker, N.; Dean, C.R.; Tao, J. Pseudomonas aeruginosa increases formation of multidrug-tolerant persister cells in response to quorum-sensing signaling molecules. J. Bacteriol. 2010, 192, 1946-1955. [CrossRef] [PubMed]
94. Ryder, C.; Byrd, M.;Wozniak, D.J. Role of polysaccharides in Pseudomonas aeruginosa biofilm development. Curr. Opin. Microbiol. 2007, 10, 644-648. [CrossRef] [PubMed]
95. Lewis, K. Multidrug tolerance of biofilms and persister cells. Curr. Top. Microbiol. Immunol. 2008, 322, 107-131. [PubMed]
96. Christensen-Dalsgaard, M.; Gerdes, K. Two higBA loci in the Vibrio cholerae superintegron encode mRNA cleaving enzymes and can stabilize plasmids. Mol. Microbiol. 2006, 62, 397-411. [CrossRef] [PubMed]
97. Budde, P.P.; Davis, B.M.; Yuan, J.; Waldor, M.K. Characterization of a higBA toxin-antitoxin locus in Vibrio cholerae. J. Bacteriol. 2007, 189, 491-500. [CrossRef] [PubMed]
98. Chan, W.T.; Moreno-Cordoba, I.; Yeo, C.C.; Espinosa, M. Toxin-Antitoxin Genes of the Gram-Positive Pathogen Streptococcus pneumoniae: So Few and Yet So Many. Microbiol. Mol. Biol. Rev. 2012, 76, 773-791. [CrossRef] [PubMed]
99. De la Cruz, M.A.; Zhao, W.D.; Farenc, C.; Gimenez, G.; Raoult, D.; Cambillau, C.; Gorvel, J.P.; Méresse, S. A toxin-antitoxin module of Salmonella promotes virulence in mice. PLoS Pathog. 2013, 9. [CrossRef] [PubMed]
100. Goulard, C.; Langrand, S.; Carniel, E.; Chauvaux, S. The Yersinia pestis chromosome encodes active addiction toxins. J. Bacteriol. 2010, 192, 3669-3677. [CrossRef] [PubMed]
101. Schuessler, D.L.; Cortes, T.; Fivian-Hughes, A.S.; ougheed, K.E.; Harvey, E.; Buxton, R.S.; Davis, E.O.; Young, D.B. Induced ectopic expression of HigB toxin in Mycobacterium tuberculosis results in growth inhibition, reduced abundance of a subset of mRNAs and cleavage of tmRNA. Mol. Microbiol. 2013, 90, 195-207. [PubMed]
102. Pandey, D.P.; Gerdes, K. Toxin-antitoxin loci are highly abundant in free-living but lost from host-associated prokaryotes. Nucleic Acids Res. 2005, 33, 966-976. [CrossRef] [PubMed]
103. Christensen-Dalsgaard, M.; Jorgensen, M.G.; Gerdes, K. Three new RelE-homologous mRNA interferases of Escherichia coli differentially induced by environmental stresses. Mol. Microbiol. 2010, 75, 333-348. [CrossRef] [PubMed]
104. Hurley, J.M.; Woychik, N.A. Bacterial Toxin HigB Associates with Ribosomes and Mediates Translation-dependent mRNA Cleavage at A-rich Sites. J. Biol. Chem. 2009, 284, 18605-18613. [CrossRef] [PubMed]
105. Mulcahy, L.R.; Burns, J.L.; Lory, S.; Lewis, K. Emergence of Pseudomonas aeruginosa Strains Producing High Levels of Persister Cells in Patients with Cystic Fibrosis. J. Bacteriol. 2010, 192, 6191-6199. [CrossRef] [PubMed]
106. Kwan, B.W.; Valenta, J.A.; Benedik, M.J.;Wood, T.K. Arrested protein synthesis increases persister-like cell formation. Antimicrob. Agents Chemother. 2013, 57, 1468-1473. [CrossRef] [PubMed]
107. Lewis, K. Persister cells, dormancy and infectious disease. Nat. Rev. Microb. 2007, 5, 48-56. [CrossRef] [PubMed]
108. Wood, T.K. Combatting bacterial persister cells. Biotechnol. Bioeng. 2016, 113, 476-483. [CrossRef] [PubMed]
109. Wang, X.; Wood, T.K. Toxin-antitoxin systems influence biofilm and persister cell formation and the general stress response. Appl. Environ. Microbiol. 2011, 77, 5577-5583. [CrossRef] [PubMed]
110. Shah, D.; Zhang, Z.; Khodursky, A.; Kaldalu, N.; Kurg, K.; Lewis, K. Persisters: a distinct physiological state of E. coli. BMC Microbiol. 2006, 6. [CrossRef] [PubMed]
111. Keren, I.; Kaldalu, N.; Spoering, A.; Wang, Y.; Lewis, K. Persister cells and tolerance to antimicrobials. FEMS Microbiol. Lett. 2004, 230, 13-18. [CrossRef]
112. (CDC) CfDC. Isolation of E. coli O157: H7 from sporadic cases of hemorrhagic colitis-United States. MMWR Morb. Mortal. Wkly. Rep. 1982, 31, 580-585.
113. Hazan, R.; Sat, B.; Engelberg-Kulka, H. Escherichia coli mazEF-mediated cell death is triggered by various stressful conditions. J. Bacteriol. 2004, 186, 3663-3669. [CrossRef] [PubMed]
114. Ren, D.; Bedzyk, L.A.; Thomas, S.M.; Ye, R.W.; Wood, T.K. Gene expression in Escherichia coli biofilms. Appl. Microbiol. Biotechnol. 2004, 64, 515-524. [CrossRef] [PubMed]
115. Brown, B.L.; Grigoriu, S.; Kim, Y.; rruda, J.M.; Davenport, A.;Wood, T.K.; Peti,W.; Page, R. Three dimensional structure of the MqsR: MqsA complex: a novel TA pair comprised of a toxin homologous to RelE and an antitoxin with unique properties. PLoS Pathog. 2009, 5. [CrossRef] [PubMed]
116. Brown, B.L.; Wood, T.K.; Peti, W.; Page, R. Structure of the Escherichia coli antitoxin MqsA (YgiT/b3021) bound to its gene promoter reveals extensive domain rearrangements and the specificity of transcriptional regulation. J. Biol. Chem. 2011, 286, 2285-2296. [CrossRef] [PubMed]
117. Wang, X.; Lord, D.M.; Hong, S.H.; Peti, W.; Benedik, M.J.; Page, R.; Wood, T.K. Type II toxin/antitoxin MqsR/MqsA controls type V toxin/antitoxin GhoT/GhoS. Environ. Microbiol. 2013, 15, 1734-1744. [CrossRef] [PubMed]
118. Kwan, B.W.; Lord, D.M.; Peti, W.; Page, R.; Benedik, M.J.; Wood, T.K. The MqsR/MqsA toxin/antitoxin system protects Escherichia coli during bile acid stress. Environ. Microbiol. 2015, 17, 3168-3181. [CrossRef] [PubMed]
119. Yamaguchi, Y.; Park, J.H.; Inouye, M. MqsR, a crucial regulator for quorum sensing and biofilm formation, is a GCU-specific mRNA interferase in Escherichia coli. J. Biol. Chem. 2009, 284, 28746-28753. [CrossRef] [PubMed]
120. Lipuma, J.J. Update on the Burkholderia cepacia complex. Curr. Opin. Pulm. Med. 2005, 11, 528-533. [CrossRef] [PubMed]
121. Mahenthiralingam, E.; Urban, T.A.; Goldberg, J.B. The multifarious, multireplicon Burkholderia cepacia complex. Nat. Rev. Microbiol. 2005, 3, 144-156. [CrossRef] [PubMed]
122. Currie, B.J.; Fisher, D.A.; Anstey, N.M.; Jacups, S.P. Melioidosis: acute and chronic disease, relapse and re-activation. Trans. R. Soc. Trop. Med. Hyg. 2000, 94, 301-304. [CrossRef]
123. Agnoli, K.; Frauenknecht, C.; Freitag, R.; hwager, S.; Jenul, C.; Vergunst, A.; Carlier, A.; Eberl, L. The third replicon of members of the Burkholderia cepacia Complex, plasmid pC3, plays a role in stress tolerance. Appl. Environ. Microbiol. 2014, 80, 1340-1348. [CrossRef] [PubMed]
124. Nieto, C.; Cherny, I.; Khoo, S.K.; e Lacoba, M.G.; Chan,W.T.; Yeo, C.C.; Gazit, E.; Espinosa, M. The yefM-yoeB toxin-antitoxin systems of Escherichia coli and Streptococcus pneumoniae: Functional and structural correlation. J. Bacteriol. 2007, 189, 1266-1278. [CrossRef] [PubMed]
125. Behnke, D.; Malke, H.; Hartmann, M.; Walter, F. Post-transformational rearrangement of an in vitro reconstructed group-A streptococcal erythromycin resistance plasmid. Plasmid 1979, 2, 605-616. [CrossRef]
126. Ceglowski, P.; Boitsov, A.; Karamyan, N.; Chai, S.; Alonso, J.C. Characterization of the effectors required for stable inheritance of Streptococcus pyogenes pSM19035-derived plasmids in Bacillus subtilis. Mol. Gen. Genet. 1993, 241, 579-585. [CrossRef] [PubMed]
127. Nieto, C.; Sadowy, E.; de la Campa, A.G.; Hryniewicz, W.; Espinosa, M. The relBE2Spn toxin-antitoxin system of Streptococcus pneumoniae: Role in antibiotic tolerance and functional conservation in clinical isolates. PLoS ONE 2010, 5. [CrossRef] [PubMed]
128. Chan, W.T.; Yeo, C.C.; Sadowy, E.; Espinosa, M. Functional validation of putative toxin-antitoxin genes from the Gram-positive pathogen Streptococcus pneumoniae: phd-doc is the fourth bona-fide operon. Front. Microbiol. 2014, 5. [CrossRef] [PubMed]
129. Tuberculosis. Available online: http://www.who.int/mediacentre/factsheets/fs104/en/ (accessed on 10 June 2016).
130. Han, J.S.; Lee, J.J.; Anandan, T.; Sripathi, S.; Jahng,W.J.; Lee, S.H.; Suh, J.W.; Kang, C.M. Characterization of a chromosomal toxin-antitoxin, Rv1102c-Rv1103c system in Mycobacterium tuberculosis. Biochem. Biophys. Res. Commun. 2010, 400, 293-298. [CrossRef] [PubMed]
131. Singh, R.; Barry, C.E.; Boshoff, H.I. The three RelE homologs of Mycobacterium tuberculosis have individual, drug-specific effects on bacterial antibiotic tolerance. J. Bacteriol. 2010, 192, 1279-1291. [CrossRef] [PubMed]
132. Korch, S.B.; Contreras, H.; Clark-Curtiss, J.E. Three Mycobacterium tuberculosis Rel toxin-antitoxin modules inhibit mycobacterial growth and are expressed in infected human macrophages. J. Bacteriol. 2009, 191, 1618-1630. [CrossRef] [PubMed]
133. Keren, I.; Minami, S.; Rubin, E.; Lewis, K. Characterization and transcriptome analysis of Mycobacterium tuberculosis persisters. MBio 2011, 2. [CrossRef] [PubMed]
134. Stinear, T.P.; Seemann, T.; Harrison, P.F.; Jenkin, G.A.; Davies, J.K.; Johnson, P.D.; Abdellah, Z.; Arrowsmith, C.; Chillingworth, T.; Churcher, C.; et al. Insights from the complete genome sequence of Mycobacterium marinum on the evolution of Mycobacterium tuberculosis. Genome Res. 2008, 18, 729-741. [CrossRef] [PubMed]
135. Zhu, L.; Sharp, J.D.; Kobayashi, H.; Woychik, N.A.; Inouye, M. Noncognate Mycobacterium tuberculosis toxin-antitoxins can physically and functionally interact. J. Biol. Chem. 2010, 285, 39732-39738. [CrossRef] [PubMed]
136. Lee, I.G.; Lee, S.J.; Chae, S.; Lee, K.Y.; Kim, J.H.; Lee, B.J. Structural and functional studies of the Mycobacterium tuberculosis VapBC30 toxin-antitoxin system: implications for the design of novel antimicrobial peptides. Nucleic Acids Res. 2015, 43, 7624-7637. [CrossRef] [PubMed]
137. Albrethsen, J.; Agner, J.; Piersma, S.R.; Højrup, P.; Pham, T.V.; Weldingh, K.; Jimenez, C.R.; Andersen, P.; Rosenkrands, I. Proteomic profiling of Mycobacterium tuberculosis identifies nutrient-starvation-responsive toxin-antitoxin systems. Mol. Cell. Proteom. 2013, 12, 1180-1191. [CrossRef] [PubMed]
138. Krupovic, M.; Gonnet, M.; Hania, W.B.; Forterre, P.; Erauso, G. Insights into dynamics of mobile genetic elements in hyperthermophilic environments from five new Thermococcus plasmids. PLoS ONE 2013, 8. [CrossRef] [PubMed]
139. Wibberg, D.; Szczepanowski, R.; Eikmeyer, F.; Puhler, A.; Schluter, A. The IncF plasmid pRSB225 isolated from a municipal wastewater treatment plant’s on-site preflooder combining antibiotic resistance and putative virulence functions is highly related to virulence plasmids identified in pathogenic E. coli isolates. Plasmid 2013, 69, 127-137. [CrossRef] [PubMed]
140. Saluja, S.K.; Weiser, J.N. The genetic basis of colony opacity in Streptococcus pneumoniae: Evidence for the effect of box elements on the frequency of phenotypic variation. Mol. Microbiol. 1995, 16, 215-227. [CrossRef] [PubMed]
141. Tiwari, P.; Arora, G.; Singh, M.; Kidwai, S.; Narayan, O.P.; Singh, R. MazF ribonucleases promote Mycobacterium tuberculosis drug tolerance and virulence in guinea pigs. Nat. Commun. 2015, 6. [CrossRef] [PubMed]
142. Helaine, S.; Cheverton, A.M.; Watson, K.G.; Faure, L.M.; Matthews, S.A.; Holden, D.W. Internalization of Salmonella by Macrophages Induces Formation of Nonreplicating Persisters. Science 2014, 343, 204-208. [CrossRef] [PubMed]
143. Proctor, R.A.; Kriegeskorte, A.; Kahl, B.C.; Becker, K.; Löffler, B.; Peters, G. Staphylococcus aureus Small Colony Variants (SCVs): A road map for the metabolic pathways involved in persistent infections. Front. Cell. Infect. Microbiol. 2014, 4, 99. [PubMed]
144. Conlon, B.P. Staphylococcus aureus chronic and relapsing infections: Evidence of a role for persister cells: An investigation of persister cells, their formation and their role in S. aureus disease. Bioessays 2014, 36, 991-996. [CrossRef] [PubMed]
145. Gelens, L.; Hill, L.; Vandervelde, A.; Danckaert, J.; Loris, R. A general model for toxin-antitoxin module dynamics can explain persister cell formation in E. coli. PLoS Comput. Biol. 2013, 9. [CrossRef] [PubMed]
146. Pecota, D.C.;Wood, T.K. Exclusion of T4 Phage by the hok/sok Killer Locus from Plasmid R1. J. Bacteriol. 1996, 178, 2044-2050. [PubMed]
147. Fineran, P.C.; Blower, T.R.; Foulds, I.J.; Humphreys, D.P.; Lilley, K.S.; Salmond, G.P. The phage abortive infection system, ToxIN, functions as a protein-RNA toxin-antitoxin pair. Proc. Natl. Acad. Sci. USA 2009, 106, 894-899. [CrossRef] [PubMed]
148. Blower, T.R.; Short, F.L.; Rao, F.; guchi, K.; Pei, X.Y.; Fineran, P.C.; Luisi, B.F.; Salmond, G.P. Identification and classification of bacterial Type III toxin-antitoxin systems encoded in chromosomal and plasmid genomes. Nucleic Acids Res. 2012, 40, 6158-6173. [CrossRef] [PubMed]
149. Samson, J.E.; Spinelli, S.; Cambillau, C.; Moineau, S. Structure and activity of AbiQ, a lactococcal endoribonuclease belonging to the type III toxin-antitoxin system. Mol. Microbiol. 2013, 87, 756-768. [CrossRef] [PubMed]
150. Anukam, K.C.; Macklaim, J.M.; Gloor, G.B.; Reid, G.; Boekhorst, J.; Renckens, B.; van Hijum, S.A.; Siezen, R.J. Genome sequence of Lactobacillus pentosus KCA1: Vaginal isolate from a healthy premenopausal woman. PLoS ONE 2013, 8. [CrossRef] [PubMed]
151. Dy, R.L.; Przybilski, R.; Semeijn, K.; Salmond, G.P.; Fineran, P.C. A widespread bacteriophage abortive infection system functions through a Type IV toxin-antitoxin mechanism. Nucleic Acids Res. 2014, 42, 4590-4605. [CrossRef] [PubMed]
152. Fiedoruk, K.; Daniluk, T.; Swiecicka, I.; Sciepuk, M.; Leszczynska, K. Type II toxin-antitoxin systems are unevenly distributed among Escherichia coli phylogroups. Microbiology 2015, 161, 158-167. [CrossRef] [PubMed]
153. Rasko, D.A.; Rosovitz, M.J.; Myers, G.S.; Mongodin, E.F.; Fricke, W.F.; Gajer, P.; Crabtree, J.; Sebaihia, M.; Thomson, N.R.; Chaudhuri, R.; et al. The pangenome structure of Escherichia coli: Comparative genomic analysis of E. coli commensal and pathogenic isolates. J. Bacteriol. 2008, 190, 6881-6893. [CrossRef] [PubMed]
154. Chowdhury, N.; Kwan, B.W.;Wood, T.K. Persistence Increases in the Absence of the Alarmone Guanosine Tetraphosphate by Reducing Cell Growth. Sci. Rep. 2016, 6. [CrossRef] [PubMed]